Pharmacokinetics of enzalutamide, an anti-prostate cancer drug, in rats

Quantitative determination of enzalutamide, an anti-prostate cancer drug, in rat plasma using liquid chromatography-tandem mass spectrometry, and its application to a pharmacokinetic study

(2014) Ji-Hye Song et al.   BIOMEDICAL CHROMATOGRAPHY

2012 FDA drug approvals

(2013) Asher Mullard   NATURE REVIEWS DRUG DISCOVERY

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

(2012) Howard I. Scher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats

(2011) Tae-Sung Koo et al.   ARCHIVES OF PHARMACAL RESEARCH

Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats

(2011) Kyeong-Ryoon Lee et al.   XENOBIOTICA

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

(2010) Howard I Scher et al.   LANCET

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

(2009) C. Tran et al.   SCIENCE